Waterless & Concentrated Formulation — Technical Specification Overview

Key Technical Parameters #

Waterless formulation briefs land on our desk almost every week now, and the challenge has shifted. A year ago, brand partners were asking “can you make it waterless?” Today the question is “what does waterless actually mean — and how do we write the spec sheet?” That distinction matters more than most people expect. Without a defined technical specification framework, two products can both be called “waterless” yet behave completely differently in stability, consumer sensory, and regulatory classification. This article lays out how we qualify and specify waterless and concentrated formats internally — focusing on the parameters that actually drive formulation decisions, not marketing positioning.

What “Waterless” Actually Specifies — And Where Definitions Break Down #

The term “waterless” has no universal regulatory definition. Under EU Cosmetics Regulation 1223/2009, a product is assessed on its actual water activity and preservative challenge, not its marketing label. We’ve had brand partners arrive with a “waterless” brief that, once we ran water activity (aw) measurement, came back at 0.82 — well within microbial risk territory. That’s not a labeling problem. That’s a formulation problem.

Internally, we segment waterless and concentrated formats into three working grades — what our team calls Grade W1, W2, and W3 — based on two primary parameters: water activity (aw) and free water content (% w/w). These grades are not an industry standard; they’re our internal QC-11 classification protocol developed from roughly four years of stability audits across our own product library. Other factories will have different thresholds.

Grade W1 (True Anhydrous): No intentional water addition. Free water ≤0.5% w/w from incidental sources (hygroscopic actives, botanical extracts). Water activity typically <0.60.

Grade W2 (Low-Moisture Concentrated): Residual or process water present, but formulated to aw <0.75. Active loading typically 3–10× higher than a standard emulsion equivalent. Preservative system may be required depending on substrate.

Grade W3 (Concentrated Emulsion / Water-Reduced): Water content reduced to 15–30% w/w from a conventional 60–75% range. aw sits between 0.80 and 0.91. Preservative challenge testing is mandatory. Consumer dilution or single-use format.

The specification gap between W1 and W3 is significant. A brand briefing us on a “waterless vitamin C serum” might be describing a W1 anhydrous oil serum — or a W3 concentrated powder-in-oil that rehydrates on contact. Those are completely different projects. We flag this in every kickoff call.

One thing that surprises brand partners: W3 formats carry more regulatory risk, not less, despite being “closer to a normal product.” The water activity range puts them in a zone where preservative challenge testing under PCPC Guidelines is expected, and some EU markets apply heightened scrutiny to concentrated rinse-off formats if dilution instructions are unclear on-pack.

The Parameter Most Spec Sheets Get Wrong: Rheology Under Use Conditions #

Viscosity gets specified. That part is fine. What almost never gets specified correctly is how viscosity behaves under use conditions — shear rate, temperature, and dilution if the format is intended to be activated.

For our waterless-concentrated formats, we measure viscosity at three shear rates: 0.1 s⁻¹ (resting/spreading assessment), 10 s⁻¹ (finger-application simulation), and 100 s⁻¹ (pump or dispense simulation). A W1 balm might read 12,000 cP at 0.1 s⁻¹ and drop to 800 cP at 100 s⁻¹. If your spec sheet only says “viscosity: 5,000–15,000 cP” without specifying shear rate, that number is almost useless for QC purposes.

Temperature dependency is the other missing parameter. Anhydrous and low-water formats are far more temperature-sensitive than conventional emulsions. A W2 concentrated serum stable at 25°C can show 40% viscosity drop at 40°C — which is within the range of a summer transit or a warm bathroom shelf. We use a temperature-sweep protocol (15°C to 45°C, 2°C/min ramp) as part of our internal W2/W3 sign-off. We call this the TS-04 profile. If the product is intended for tropical markets, anything that drops below 500 cP at 40°C gets flagged before pilot batch.

The clinical angle here matters too. A 2022 split-face study (n=34, 8 weeks, peer-reviewed, published in International Journal of Cosmetic Science) comparing a W1 anhydrous retinoid balm against an equivalent water-based emulsion found 27% greater transepidermal water loss (TEWL) reduction in the balm arm — attributed to the occlusive vehicle rather than retinoid concentration alone. What that study doesn’t report is viscosity at application shear rate. We’re not sure whether the improved barrier outcome was partly a rheology effect. The mechanism isn’t fully resolved, and we’d want to see that variable controlled before claiming it as a formulation principle.

The broader point: brand partners often specify “must feel light” and “must absorb fast” without understanding that these are contradictory targets in a high-active-load anhydrous format. A W1 serum with 20% vitamin C derivative and 15% niacinamide will not absorb the way a 30% water-containing emulsion does. We almost always push back on that brief before the formulation direction is locked.

Corrective Actions When a Waterless Spec Fails Qualification #

This is where projects actually get expensive. The spec table gets written, pilot batches get made, and then something fails at week 8 of accelerated stability. Here’s how we rank the interventions:

1. Redo the aw measurement with the final raw material lot, not the reference standard. Water activity can shift 0.04–0.08 units between supplier lots of hygroscopic ingredients like hyaluronic acid powder or glycerin. We’ve caught aw drift from 0.71 to 0.79 between two nominal-identical HA lots — enough to change the preservative decision. This is cheap to fix if caught early. Expensive if you’re already in bulk.

2. Tighten the incoming raw material moisture spec. Most buyers accept the supplier’s CoA moisture value. For W1 and W2 grades, we require incoming moisture testing on every lot of hygroscopic actives. Our threshold is ≤1.5% moisture on powder actives entering a W1 formulation. Anything above that gets quarantined and re-evaluated.

3. Reformulate the solvent system. If aw is drifting because the base emollient blend is picking up atmospheric moisture during processing, the answer is usually to increase the proportion of low-polarity esters or silicones. This is a medium-effort reformulation — typically 2–3 additional pilot batches.

4. Revise the manufacturing environment spec. W1 and W2 manufacture should happen at ≤40% relative humidity. If the production environment runs at 55–65% RH (common in summer in southern production facilities), the product will absorb atmospheric water during open processing steps. Some brands don’t realize the factory environment is part of their product specification.

5. Change the packaging before changing the formula. Airless and hermetic formats prevent post-fill moisture ingress during consumer use. We’ve seen aw climb from 0.68 to 0.79 over 6 months in a product packed in a jar — purely from repeated consumer opening. Switching to an airless pump resolved the drift without any formulation change. Packaging is often the faster path. See our related encapsulation-technology guidance for active protection considerations in concentrated formats.

Trade-off worth stating plainly: options 1 and 2 are fast and cheap. Option 5 requires a packaging retool which may push your MOQ or unit cost. Option 3 and 4 are the most thorough solutions but add 4–6 weeks to the timeline. We usually recommend running options 1 and 2 in parallel with option 5 before committing to a full reformulation.

What to Specify Upfront — Before the First Pilot Batch #

Procurement teams and brand developers writing supplier briefs for waterless formats tend to under-specify. The most common gap: the brief says “waterless serum, 30ml airless, EU market” but doesn’t specify aw target, active load range, or whether the format is intended as a standalone or a pre-serum concentrate. Each of those decisions changes the formulation grade and the qualification burden.

At minimum, a waterless brief submitted to a manufacturing partner should define:

• Target aw range (or, if unknown, the free water % ceiling you’re willing to accept)
• Active ingredient identity and target load — not just “high actives” but specific INCI names and % targets
• Primary market — NMPA Cosmetic Regulation has different preservative reporting expectations than the EU, and this affects which grade of preservative system (or absence thereof) can be justified in submission documents
• Consumer use format — neat application vs. mix-in vs. peel-and-apply. The use format determines whether your aw spec is for the product-as-sold or product-as-used.
• Packaging format and fill environment RH requirement

Request from your supplier: a completed QC datasheet showing aw, free water %, viscosity at 10 s⁻¹, and a minimum 4-week accelerated stability read at 40°C/75% RH before pilot sign-off. If they can’t provide that, the spec is incomplete.

Formulation Notes for Brand Partners #

When you brief us on a waterless or concentrated format, the first thing we ask is: what market, what format, and what’s the on-pack story? Those three questions immediately tell us which grade we’re working in and what the qualification path looks like.

The brief mistake we see most often is conflating “no water on the ingredient list” with “no preservative needed.” Water activity is the controlling variable, not the presence or absence of “aqua” in the INCI. A brief that says “preservative-free, clean label, waterless” can still fail microbial challenge if the emollient blend includes even modest levels of polyols or hydrophilic actives that depress aw into the risk zone. We reframe this in the first technical call — because finding it at week 8 of stability is a much worse conversation.

Timeline for waterless projects is typically: lab samples in 2–3 weeks from brief confirmation, accelerated stability at 40°C/75% RH run for 4–8 weeks with interim reads at weeks 2 and 4, and 24-month real-time stability initiated concurrently from pilot batch sign-off. For W3 grades requiring preservative challenge, add 4 weeks for microbial testing. If your target market requires NMPA Cosmetic Regulation filing, factor in an additional 3–6 months post-formula lock for registration documentation.

Frequently Asked Questions #

Our brief says “waterless” — do we still need a preservative?
A: Depends on your aw, not your INCI list. If the formula contains polyols, certain botanical extracts, or hydrophilic powders, your aw can sit above 0.75 even with no free water added — and at that point preservative challenge testing under PCPC Guidelines is expected. We test aw on every pilot batch before making that call.

We want to make a concentrated serum — how concentrated is actually achievable?
A: In a W1 anhydrous format, we’ve formulated active loads up to 35–40% w/w for certain vitamin C derivatives and peptide complexes. Realistically, solubility limits and sensory acceptability start competing with each other above 25%. For most briefs, 15–20% active load is the practical ceiling before texture becomes a problem for the end user.

What’s the stability risk we’re most likely to miss?
A: aw drift from raw material variation. We audited incoming lots over an 18-month window and found that hygroscopic powder actives from the same supplier can vary enough between lots to shift your formula’s aw by 0.06 units. For a formula sitting at aw 0.73, that variance can push you across the 0.75 threshold we use as our W2/W3 decision point. That failure mode shows up slowly — usually not until week 8 or 12 of accelerated stability — and by then you’ve committed significant development time.

What’s your MOQ for waterless formats, and how long does development take?
A: MOQ for pilot batches starts at 50 kg for most anhydrous and low-moisture formats. Commercial production MOQ is typically 200–500 kg depending on the format and filling line required. Development from brief to approved pilot sample runs 6–10 weeks for a straightforward W1 or W2 format; add 4–6 weeks for W3 grades that require preservative challenge testing.

We’re targeting both the EU and the US — do we need separate specs for each market?
A: The formulation can usually be the same. The documentation burden is different. Under EU Cosmetics Regulation 1223/2009, your product information file needs explicit justification for any absence of a conventional preservative system — and that justification has to reference the aw data. The FDA under FDA Cosmetics Guidelines doesn’t currently require the same level of aw documentation, but we build it into the dossier anyway because if you’re asked for it later, you want it ready. The spec should be written to the stricter standard from day one.

---

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.